Hyperfine, Inc.
For the period ended Mar 31, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 13, 2025
HYPR$0.68-3.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (unaudited)
(Unaudited)
(in thousands, except share and per share amounts)
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $33,093 | $37,645 |
| Restricted cash | 441 | 28 |
| Accounts receivable, less allowance of $790 and $651 as of March 31, 2025 and December 31, 2024, respectively | 5,330 | 5,956 |
| Unbilled receivables | 1,937 | 2,349 |
| Inventory | 4,639 | 5,832 |
| Prepaid expenses and other current assets | 2,963 | 1,900 |
| Total current assets | 48,403 | 53,710 |
| Property and equipment, net | 3,094 | 3,122 |
| Other long term assets | 1,880 | 2,069 |
| Total assets | $53,377 | $58,901 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable | $2,305 | $1,607 |
| Deferred grant funding | 441 | 28 |
| Deferred revenue | 1,406 | 1,460 |
| Due to related parties | 54 | 61 |
| Accrued expenses and other current liabilities | 3,773 | 5,573 |
| Total current liabilities | 7,979 | 8,729 |
| Warrant liabilities | 1,240 | — |
| Long term deferred revenue | 1,028 | 1,054 |
| Other noncurrent liabilities | 16 | 78 |
| Total liabilities | 10,263 | 9,861 |
| COMMITMENTS AND CONTINGENCIES (NOTE 13) | ||
| STOCKHOLDERS' EQUITY | ||
| Class A Common stock, $0.0001 par value per share; 600,000,000 shares authorized; 62,784,562 and 58,076,261 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 6 | 5 |
| Class B Common stock, $0.0001 par value per share; 27,000,000 shares authorized; 15,055,288 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 2 | 2 |
| Additional paid-in capital | 346,966 | 343,475 |
| Accumulated deficit | (303,860) | (294,442) |
| Total stockholders' equity | 43,114 | 49,040 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $53,377 | $58,901 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.